10,000-share option exercise; insider sales by Stephen Rohde (SLDE)

Rhea-AI Filing Summary

SLDE reports proposed and recent transactions by Stephen Rohde and a planned option exercise. The filing lists a 03/13/2026 planned stock option exercise for 10,000 Common shares (cash exercise). It also records recent sales by Stephen Rohde: 9,335 shares on 02/27/2026 for $175,778.05, 5,000 shares on 03/03/2026 for $95,800.00, and 5,000 shares on 03/04/2026 for $97,500.00.

Insights

Securities Compliance Counsel

Routine Rule 144 sales and a scheduled option exercise are disclosed.

The filing lists proposed sale activity under Rule 144 and a cash exercise of stock options for 10,000 Common shares on 03/13/2026. The recorded dispositions by Stephen Rohde total 19,335 shares across 02/27/2026–03/04/2026 with aggregate proceeds shown.

These entries are compliance disclosures of transactions; cash‑flow treatment is shown for each sale as the reported consideration amounts. Subsequent filings or broker confirmations would provide settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	177800.00	124319406	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/13/2026	Stock Option Exercise	Issuer			10000	03/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STEPHEN ROHDE 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	03/04/2026	5000	97500.00
STEPHEN ROHDE 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	03/03/2026	5000	95800.00
STEPHEN ROHDE 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	02/27/2026	9335	175778.05

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)